Biotechnology
| Sat 13 Dec 2025
Beijing, Dec. 13 -- BioVersys has submitted a patent application for Rifbutin Analogs for Treatment of Disease. Antraygue Kyle, Brodt Michael, Dale Gregory E, Thetford Oliver, Gitzinger Martin, Loukiulo Seppo, Meingert Michael, Trebos Valentin and Willand Nicolas developed the invention.
The patent application number is CN202..